- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HEARTBEAM Aktie jetzt für 0€ handeln | |||||
| 14.08. | HeartBeam schließt Aktienverkaufsvereinbarung über 25 Millionen US-Dollar mit Titan Partners | 2 | Investing.com Deutsch | ||
| 14.08. | HeartBeam, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.08. | HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss | 2 | Investing.com | ||
| 13.08. | HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript | 1 | Benzinga.com | ||
| 13.08. | Heartbeam Aktie: Quartalsverlust belastet nachbörslichen Kurs | 1 | Investing.com Deutsch | ||
| 14.07. | HeartBeam receives patent for multi-modal cardiac sensing device | 1 | Investing.com | ||
| 02.07. | HeartBeam, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.06. | HeartBeam, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.05. | H.C. Wainwright cuts Heartbeam stock price target on slower sales ramp | 1 | Investing.com | ||
| 15.05. | Benchmark cuts Heartbeam stock price target on dilution to $5 | 1 | Investing.com | ||
| 13.05. | Earnings Call: HeartBeam übertrifft EPS-Prognose für Q1 2026 - Aktie legt nachbörslich zu | 2 | Investing.com Deutsch | ||
| 13.05. | HeartBeam Q1 2026 Earnings Call: Complete Transcript | 4 | Benzinga.com | ||
| 13.05. | HeartBeam GAAP EPS of -$0.12 beats by $0.02 | 1 | Seeking Alpha | ||
| 13.05. | HeartBeam, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.05. | HeartBeam starts pilot study of on-demand 12-lead ECG patch | - | MassDevice | ||
| 24.04. | HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold Forever | 16 | Insider Monkey | ||
| 20.04. | Heartbeam: D. Boral Capital stuft Aktie wegen Konditionen der Kapitalerhöhung herab | 16 | Investing.com Deutsch | ||
| 20.04. | D. Boral Capital cuts Heartbeam stock rating on capital raise terms | 1 | Investing.com | ||
| 16.04. | HeartBeam closes $10M public offering for product rollout | 1 | Investing.com | ||
| 16.04. | HeartBeam, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,240 | +0,61 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 23 Euro auf "Buy" belassen. Die operative Grundleistung des Herstellers radioaktiver... ► Artikel lesen | |
| UNITEDHEALTH | 340,40 | +0,35 % | Billionaire David Tepper Sold Every Single Share of UnitedHealth in Q2. Here's Whether He Made a Costly Mistake. | ||
| THERMO FISHER | 537,20 | +0,04 % | Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery? | ||
| DEXCOM | 77,80 | -0,77 % | Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now? | ||
| RESMED | 205,50 | -0,92 % | RESMED INC: LR 1.15.3 Compliance | ||
| HEALWELL AI | 0,482 | -0,52 % | HEALWELL AI: HEALWELL AI's DARWEN AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation | Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN AI as a globally recognized... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,240 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| LIFEWARD | 7,500 | +0,40 % | Lifeward Ltd.: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth | Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial... ► Artikel lesen | |
| IMUNON | 1,380 | 0,00 % | Imunon to host R&D day on Sept. 23 for ovarian cancer therapy | ||
| INSPIREMD | 0,780 | +5,41 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| MYOMO | 1,360 | -1,88 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| GT BIOPHARMA | 0,300 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2026 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3... ► Artikel lesen | |
| INOGEN | 4,660 | -0,85 % | Inogen (INGN) Cuts Guidance Even As Profitability Climbs | ||
| INTELLIGENT BIO SOLUTIONS | 2,330 | 0,00 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| CATHETER PRECISION | 0,203 | +0,25 % | Catheter Precision, Inc.: Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany | Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business Johns Hopkins Hospital, a world-renowned academic... ► Artikel lesen |
Das Unternehmen HEARTBEAM INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,467 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTBEAM INC finden Sie auf Wallstreet Online.